Domain I of the 5′ non-translated genomic region in coxsackievirus B3
RNA is not required for productive replication by Jaramillo, L. et al.
University of Nebraska - Lincoln
DigitalCommons@University of Nebraska - Lincoln
Virology Papers Virology, Nebraska Center for
2016
Domain I of the 5′ non-translated genomic region
in coxsackievirus B3 RNA is not required for
productive replication
L. Jaramillo
University of Nebraska Medical Center
S. Smithee
University of Nebraska Medical Center
S. Tracy
University of Nebraska Medical Center
N. M. Chapman
University of Nebraska Medical Center
Follow this and additional works at: http://digitalcommons.unl.edu/virologypub
Part of the Biological Phenomena, Cell Phenomena, and Immunity Commons, Cell and
Developmental Biology Commons, Genetics and Genomics Commons, Infectious Disease
Commons, Medical Immunology Commons, Medical Pathology Commons, and the Virology
Commons
This Article is brought to you for free and open access by the Virology, Nebraska Center for at DigitalCommons@University of Nebraska - Lincoln. It
has been accepted for inclusion in Virology Papers by an authorized administrator of DigitalCommons@University of Nebraska - Lincoln.
Jaramillo, L.; Smithee, S.; Tracy, S.; and Chapman, N. M., "Domain I of the 5′ non-translated genomic region in coxsackievirus B3 RNA
is not required for productive replication" (2016). Virology Papers. 352.
http://digitalcommons.unl.edu/virologypub/352
Domain I of the 5′ non-translated genomic region in coxsackievirus B3
RNA is not required for productive replication
L. Jaramillo a,b, S. Smithee a,c, S. Tracy a, N.M. Chapman a,n
a Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE 68198-6495, USA
b Department of Pharmaceutical Sciences, University of Nebraska Medical Center, Omaha, NE 68198-5830, USA
c Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA
a r t i c l e i n f o
Article history:
Received 6 April 2016
Returned to author for revisions
23 May 2016
Accepted 24 May 2016
Available online 9 June 2016
Keywords:
Coxsackievirus
Enterovirus
5′ terminal deletion
Cloverleaf
Domain I
RNA structure
a b s t r a c t
Domain I is a cloverleaf-like secondary structure at the 5′ termini of all enterovirus genomes, comprising
part of a cis-acting replication element essential for efficient enteroviral replication. 5′ genomic terminal
deletions up to as much as 55% of domain I can occur without lethality following coxsackie B virus
infections. We report here that the entire CVB structural domain I can be deleted without lethality.
& 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
The six group B coxsackievirus serotypes (CVB1–6) are species
B human enteroviruses (Picornaviridae) (Tracy et al., 2008). Do-
main I (Fig. 1A) of the 5′ nontranslated region (NTR) RNA structure
(Bailey and Tapprich, 2007) is located at the genome’s 5′ terminus
and is required for efficient replication (Andino et al., 1990). It has
been demonstrated that naturally-occurring deletions of 7–49
nucleotides from the 5′ terminus of CVB3 genome are not lethal for
the virus populations and occur following experimental inocula-
tion of primary cell cultures (Kim et al., 2008) and of mice (Kim
et al., 2005; Tracy et al., 2015) as well as after naturally-occurring
human infections (Chapman et al., 2008). Group B coxsackievirus
virions containing 5′ terminally deleted genomes (CVB-TD) can be
isolated, replicate productively in the absence of parental (wild-
type) CVB genomes, and infections are inhibited using neutralizing
antibody (Kim et al., 2005; Smithee et al., 2015). CVB3-TD genomes
have 5′ terminal sequences which can have any of the 4 ribonu-
cleotides (Chapman et al., 2008; Kim et al., 2008; Kim et al., 2005)
despite the presence of covalently attached VPg (Kim et al., 2005).
CVB-TD populations demonstrate impaired replication with re-
plication levels that are 100,000 fold lower than wildtype virus
(Smithee et al., 2015).
CVB3-TD populations with deletions greater than 49 nucleo-
tides in length have not been detected in either cell culture ex-
periments or from human CVB-TD isolates (Chapman et al., 2008;
Kim et al., 2008; Kim et al., 2005). As domain I is one of 4 char-
acterized cis-acting replication elements [CRE;(Paul and Wimmer,
2015)] which aid enteroviral replicational efficiency, we were
curious to determine whether larger deletions of domain I were
lethal, thus accounting for failing to detect them. We experimen-
tally deleted nucleotides 1–77 from an infectious cDNA copy of a
CVB3 genome (Tracy et al., 2002), thereby excising domain I
through stem-loop d. This construct, CVB3-TD78, was viable and
produced infectious progeny virus.
2. Results and discussion
A CVB3 genome with a deletion of the 5′ 77 nucleotides (nt1–
77) (Fig. 1A, C) was engineered to include an upstream T7 pro-
moter and a ribozyme designed to generate transcripts with the 5′
termini beginning at nt78 (Fig. 1B); this construct was termed
pCVB3-TD78. HeLa cell monolayers were electroporated with full-
length CVB3 RNA T7 RNA polymerase transcript from Cla1-di-
gested pCVB3–28 (wt, positive control) or pCVB3-TD78 (Smithee
et al., 2015). While electroporation with wt CVB3/28 RNA pro-
duced extensive cytopathic effect (CPE) at 48 h in cell cultures, no
CPE was observed in cultures electroporated with CVB3-TD78 RNA
or in control (non-electroporated) HeLa cell monolayers similar to
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results with other CVB-TD strains (Kim et al., 2008; Kim et al.,
2005; Smithee et al., 2015).
Virus was isolated from previously electroporated HeLa
monolayers by freeze-thawing, followed by treatment of the
cleared lysates with ribonuclease, and pelleting virions through a
30% sucrose cushion (Kim et al., 2005; Smithee et al., 2015). Viral
RNA isolated from pelleted and resuspended wt and CVB3-TD78
virions was detected by semi-nested reverse transcription poly-
merase chain reaction (RT-PCR) (Smithee et al., 2015) using a 5′
terminal primer annealing to the region after the RNA structure
(S5, Table 1). Viral RNA was detectable in both samples, demon-
strating that electroporation had induced productive viral re-
plication as only newly synthesized viral RNA is encapsidated in
progeny virions (Nugent et al., 1999) (Fig. 2A). RT-PCR mediated
detection of sequences within the deleted region (Smithee et al.,
2015) was consistent with the expected 78 nucleotide deletion
(Fig. 2B) in which the S4 (Table 1) annealing site was deleted.
Because CVB3-TD78 induced no apparent CPE, as expected from
previous work characterizing CVB-TD strains (Kim et al., 2008;
Kim et al., 2005; Tracy et al., 2015), RT-qPCR was used to quanti-
tate positive strand viral RNA (Smithee et al., 2015) with the titer
expressed as positive strand viral RNA molecules per cell (Fig. 2C).
Similar to results reported for other CVB-TD populations (Smithee
et al., 2015), CVB3-TD78 replicated to approximately 100,000
times lower extent than did the wt virus, CVB3-28.
To test that the detected CVB3-TD78 viral RNA was en-
capsidated, virions were inoculated onto HeLa cell monolayers
with (Fig. 3C) or without (Fig. 3D) prior incubation with anti-CVB3
neutralizing serum (ATCC; Manassas VA). No apparent CPE was
observed for either CVB3-TD78 sample, while extensive CVB3/28-
induced CPE was completely inhibited by neutralizing antibody
(Fig. 3E,F). Then, using total RNA isolated from CVB3-TD78 cultures
inoculated in the presence or absence of neutralizing serum to test
for viral RNA by RT-PCR, viral RNA was detectable only in cultures
which had not previously been treated with neutralizing antibody
(Fig. 3G,H), indicating that a productive CVB3-TD78 infection was
inhibited by CVB3-neutralizing antibody.
Results presented here demonstrate that an enteroviral gen-
ome which lacks all of domain I (nt1–77) still replicates produc-
tively, albeit to significantly lower titers than wt virus. It is known
that domain I is required to form a ribonucleoprotein complex that
promotes efficient replication of the viral genome (Andino et al.,
1993). This complex forms with the binding of poly(C) binding
protein 1 (PCBP) to stem-loop b and 3CDpr° to stem-loop d which
Fig. 1. pCVB3-TD78 deletion and plasmid map. (A) The structure of the 5′ non-
translated region of CVB3 indicating deleted sequence (blue) and conserved region
(black) in TD78. (B) Ribozyme sequence (red) [as in (Wedekind and McKay, 1998)]
of the 5′ end of T7 RNA transcript. (For interpretation of the references to color in
this figure legend, the reader is referred to the web version of this article.)
Table 1
Primers used in this work.
Primer Sequence (5′3′) Annealing site
E3 ACACGGACACCCAAAGTAGTCGGTTCC Reverse Complement 537–563 (Chapman et al., 1990)
TD78RiboZ1 ATGAGGCCGAAAGGCCGAAAACCCGGTATCCCGGGTTCGCCTGTTTTATACCCCCTCCCCCA
TD78RiboZ2 CACTATAGGGCGCGGGAAACAGGCCTGATGAGGCCGAAAGGCCGAAAAC
RIBOZPCRT7 GACCGCGGCCGCGTAATACGACTCACTATAGGGCGCGGG
S4 CGCTAGCACTCTGGTATCACGGTACCTTTG 45–74 (Kim et al., 2005)
S5 TATACCCCCTCCCCCAACTGTAACTTAG 86–113 (Smithee et al., 2015)
E3Sub AGTAGTCGGTTCCGC Reverse Complement 535–549 (Smithee et al., 2015)
SReturn TACACTGGGGTAGTGCTGAGCG Reverse Complement 291–312 (Smithee et al., 2015)
Fig. 2. Replication of CVB3-TD78. (A) RNA from purified virions of HeLa cultures
72 h post electroporation was reverse transcribed [primer E3; (Chapman et al.,
1990)], amplified with S5 and E3Sub, reamplified with S5 and SReturn. (B) cDNA
from virion RNA as in (A) was amplified with S4 (Kim et al., 2005) and E3Sub and
reamplified with S4 and SReturn. Lanes 1 and 9, HiLo ladder (Minnesota Mole-
cular); 2, no RNA; 3, no DNA; 4, untransfected HeLa preparation; 5–7, CVB3-TD78
transfected HeLa cell culture preparations; 8, CVB3-28 transfected HeLa cell culture
preparation. (C) Quantitative RT-PCR on purified virion RNA from multiple trans-
fected cultures. No signal above background was detected for negative controls.
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in turn allows genome circularization (Barton et al., 2001; Gama-
rnik and Andino, 2000; Herold and Andino, 2001). The ability of
TD viruses without stem-loop b to replicate, as exemplified with
CVB3-TD50 (which lacks the 5′ nt1–49) (Kim et al., 2005), may be
due to the binding of PCBP to the spacer region between domain I
and II (Zell et al., 2008), a location that also remains intact in
CVB3-TD78. Mutations in the poliovirus domain I (Andino et al.,
1990; Trono et al., 1988) also showed loss of CPE (interpreted as
lethal) when mutations disrupted stemloop d RNA structure. In-
terestingly, as observed with CVB-TD strains, such mutations also
decreased RNA synthesis levels as well as the ratio of positive to
negative strand RNA (Andino et al., 1990; Vogt and Andino, 2010).
As our results for the TD78 deletion demonstrated a decrease in
virus replication at a level similar to that observed for naturally-
generated TD strains (which maintain the stemloop d of domain I)
(Smithee et al., 2015), it is possible that some of the mutations of
the cloverleaf reported as “dead” (Andino et al., 1990), might have
actually replicated at similarly low levels of the CVB-TD viruses.
We previously demonstrated that the terminal deletion size of
a CVB-TD genome can increase in size; this was observed following
passage of CVB3-TD8 (which deleted the 5′ 7 nt) in primary cell
cultures or in mice (Kim et al., 2008; Kim et al., 2005). However,
we did not observe an evolution of the terminal deletion popula-
tions of passaged CVB3-TD50 (containing a 5′ 49 nt deletion) to
larger deletions, which would erode or eliminate stemloop d (Kim
et al., 2008; Kim et al., 2005). The observation that CVB3-TD78 was
replication competent in HeLa cell cultures at a level similar to
CVB3-TD50 was surprising, for if CVB3-TD78 replicates as well as
efficiently as CVB3-TD50, why was there no evolution to a popu-
lation of larger deletions during passage of CVB3-TD50? We sug-
gest this may be due to the non-selective (permissive) nature of
HeLa cells for enterovirus replication. We know that CVB3-TD are
not generated by passage of CVB3 in HeLa cell culture (Kim et al.,
2008) but are selected in passage in hearts and pancreas of mice
(Kim et al., 2005; Tracy et al., 2015) or in primary cell cultures (Kim
et al., 2008). While the 5′ terminal deletion of stemloop d may not
be necessary for 5′ terminally deleted enterovirus replication, it is
possible that there is some loss of efficiency generated by deletion
of this sequence, sufficiently so to prevent CVB-TD populations
from accumulating a population without stemloop d in hearts or
primary cells. This discrete loss of replicational efficiency may be
sufficient to select against CVB-TD populations that delete the
entire domain I. The loss of approximately 50 5′ nt (as in CVB3-
TD50) may represent the peak of fitness in the evolving TD po-
pulations and while larger 5′ terminal deletions may transiently
occur in a cell’s quasispecies virus population, they never become
dominant (Garcia-Arriaza et al., 2006).
The finding that the 5′ NTR domain I, one of 4 CREs that pro-
mote replication efficiency, can be deleted from the CVB3 genome
without lethal consequences for the virus, is novel and comple-
ments and extends others’ studies showing that other CREs can
also be deleted and are similarly unnecessary for enteroviral
Fig. 3. Passage of CVB3-TD78. (A–F) Purified CVB3-TD78 (C,D) or CVB3/28 (E,F) virions were inoculated onto HeLa cell cultures with (C,E) or without (D,F) prior incubation
(1 h, 37 °C) with anti-CVB3 neutralizing serum diluted 1:400 in complete cell culture medium. Uninoculated HeLa culture (B) was also incubated with antibody (A). (G,H) RT-
PCR of RNA from day 5 HeLa cultures inoculated with virus in the absence or presence of anti-CVB3 serum (RT using E3, 1st PCR S5/E3Sub, 2nd S5/SReturn). G1,10, H1,8: HiLo
ladder; G2–5: CVB3/TD78 (G2,3 with antibody). G6–9: CVB3/28 (G6,7 with antibody); H4–7: HeLa culture (H4,5 with antibody); H2: no RNA; H3: no DNA.
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replication, viz. the 3′ NTR (Todd et al., 1997) and the CRE(2C)
(Smithee et al., 2015). That modern enteroviruses can lose a CRE
that, when present, confers greater adaptability upon the genome
in a given environment through improved replication, is intri-
guing. These findings cumulatively beg the question how much of
an enteroviral genome might be deleted or, as in the case of the
CRE(2C), made non-functional, while maintaining the capacity to
replicate productively. Assuming that the ancient enteroviral
genomic ancestors were basic RNA replicons, how might, and in
what order could, such beneficial genomic domains have been
added as the genomic design evolved. Further studies employing
enteroviruses with deletions of multiple CREs (such as recently
reported in a CVB3 genome; Smithee et al., 2015), may shed light
on pathways by which evolving evolutionary ancestor virus po-
pulations acquired these capabilities.
3. Materials and methods
Construction of CVB3 cDNA genome with deletion of nt1–77:
Briefly, pCVB3–28 (Tracy et al., 2002) DNA was linearized by di-
gestion with ClaI and amplified with 0.5 mM of primers E3
(Chapman et al., 1990) and TD78RiboZ1 (Table 1) using Deep Vent
DNA polymerase (New England Biolabs, Ipswich, MA) in 200 mM
dNTPs, 6 mM Mg2SO4 and using 1 cycle at 94 °C for 5 min and 35
cycles (94 °C for 30 s, 62 °C for 30 s, and 72 °C for 60 s). This pro-
duct was column purified (DNA Clean & Concentrator-5, Zymo
Research, Irvine, CA) and amplified with E3 and TD78RiboZ2 (Ta-
ble 1) with the same conditions and polymerase and again column
purified prior to a final amplification with E3 and RibozT7PCR
(Table 1). A 0.54 kb NotI, PstI restriction fragment of this product
was ligated into a 9.8 kb NotI, PstI pCVB3/28 restriction fragment
to remove nt1–77 of the cDNA genome and to incorporate a TD78
specific ribozyme (Fig. 1B) (Chapman et al., 2008; Kim et al., 2005).
pCVB3–28 and pCVB3-TD78 have the viral cDNA in opposite or-
ientation to the ampicillin resistance gene, an orientation with
increased stability of the viral cDNA insert. The sequence of the
construct was confirmed (data not shown).
Generation of CVB3/TD78 and CVB3/28: ClaI-digested pCVB3–
28 and pCVB3-TD78 plasmid DNA was transcribed with T7 poly-
merase (Ribomax T7, Promega, Madison, WI) for 1 h at 37 °C. T7
transcripts were digested with with RQ1 DNase (Promega) in the
presence of 2 mM CaCl2 and concentrated by precipitation in 2 M
LiCl at 4 °C, then pelleting the RNA at 12,000 rpm for 20 min. HeLa
cell monolayers were electroporated with full-length CVB3 RNA T7
RNA polymerase transcripts of pCVB3/28 (wt, positive control) or
pCVB3-TD78 (Smithee et al., 2015). Virions from CVB3-TD78
transfection cultures were prepared after 72 h, centrifugally
cleared of cellular debris, incubated with ribonuclease A to de-
grade non-encapsidated RNA, and concentrated by ultra-
centrifugation through 30% w/v sucrose columns (Kim et al., 2005;
Smithee et al., 2015). Viral RNA was isolated with Trizol (Ambion,
Foster City, CA). Viral RNA concentration of stocks was determined
with RT-qPCR (Smithee et al., 2015).
Detection of viral RNA in electroporated HeLa monolayers: Viral
RNA from wt and CVB3-TD78 virions was reverse transcribed
(Smithee et al., 2015) using the primer E3 (Chapman et al., 1990),
then enzymatically amplified using primers S5 (nt 86–113) and
E3Sub (Smithee et al., 2015) using GoTaq (Promega) in GoTaq 1X
complete master mix (Promega; Madison, WI) for 1 cycle at 94 °C
for 5 min and 35 cycles (94 °C for 10 s, 56 °C for 5 s, and 72 °C for
35 s) followed by amplification with primers S5 and SReturn or
using S4 (nt 45–74) and E3Sub and S4 and SReturn (Smithee et al.,
2015). Primers are shown in Table 1.
Detection of passage of CVB3 in HeLa monolayers: Virions
(isolated as described) were inoculated onto HeLa cell monolayers
with or without prior incubation (1 h, 37 °C) with anti-CVB3
neutralizing serum diluted 1:400 (ATCC; Manassas, VA) (Smithee
et al., 2015). Total RNA was isolated with Trizol at day 5 and viral
RNA was detected using semi-nested RT-PCR using E3 (RT) and S5/
E3Sub and S5/SReturn (PCR) as described.
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